These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 10980855)

  • 1. Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias.
    Krol RB; Saksena S; Prakash A
    Curr Cardiol Rep; 1999 Nov; 1(4):282-8. PubMed ID: 10980855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of antiarrhythmic drugs and implantable devices in controlling ventricular tachycardia and fibrillation.
    Rajawat YS; Dias D; Gerstenfeld EP; Dixit S; Shah B; Russo AM; Marchlinski FE
    Curr Cardiol Rep; 2002 Sep; 4(5):434-40. PubMed ID: 12169241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?
    Ho A; Assadi R; Pai SM; Pai RG
    Curr Cardiol Rep; 2006 Sep; 8(5):365-9. PubMed ID: 16956452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between pharmacologic and nonpharmacologic antiarrhythmic therapy.
    Greene HL
    Am J Cardiol; 1996 Aug; 78(4A):61-6. PubMed ID: 8780330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining antiarrhythmic drugs and implantable devices therapy: benefits and outcome.
    Santini M; Pandozi C; Ricci R
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():65-8. PubMed ID: 10590491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
    Singh BN
    Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions.
    Marchlinski FE; Zado ES; Deely MP; Saligan J; Ashar M; Nayak H
    Am J Cardiol; 1999 Nov; 84(9A):69R-75R. PubMed ID: 10568663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implantable defibrillator and antiarrhythmic drugs--competitive and complementary treatment for severe ventricular arrhythmia.
    Dorian P; Newman D
    Clin Cardiol; 1993 Nov; 16(11):827-30. PubMed ID: 8269662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between antiarrhythmic drugs and implantable cardioverter-defibrillators.
    Dougherty AH
    Curr Opin Cardiol; 1996 Jan; 11(1):2-8. PubMed ID: 8664528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third- and fourth-generation implantable cardioverter defibrillators: current status and future development.
    Saksena S; Diaz ML; Varanasi S; Mathew P; Berg J; Krol RB; Kaushik RR
    J Interv Cardiol; 1994 Oct; 7(5):427-40. PubMed ID: 10155192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators.
    Stevens SK; Haffajee CI; Naccarelli GV; Schwartz KM; Luceri RM; Packer DL; Rubin AM; Kowey PR
    J Am Coll Cardiol; 1996 Aug; 28(2):418-22. PubMed ID: 8800119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between drugs and devices: experimental and clinical studies.
    Manz M; Jung W; Lüderitz B
    Am Heart J; 1994 Apr; 127(4 Pt 2):978-84. PubMed ID: 8160602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
    Domanski MJ; Sakseena S; Epstein AE; Hallstrom AP; Brodsky MA; Kim S; Lancaster S; Schron E
    J Am Coll Cardiol; 1999 Oct; 34(4):1090-5. PubMed ID: 10520795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.